CRs and post-CR relapse after each treatment
. | N, % . | |||||
---|---|---|---|---|---|---|
Line of therapy | First line | Second line | Third line | Fourth line | Fifth line | Sixth line |
Treated | 66 | 38∗ | 21† | 14‡ | 4 | 3 |
Achieved complete response | 35 (53%) | 18 (51%) | 7 (35%) | 2 (17%) | 2 (50%) | 2 (67%) |
Relapsed after complete response | 22/35 (63%) | 11/18 (61%) | 6/7 (86%) | 2/2 (100%) | 1/2 (50%) | 0/2 (0%) |
Time from previous line (IQR), mo | NR | 3.4 (2.7-7.6) | 3.1 (1.9,6.1) | 3.9 (2.3-6.6) | 1.4 (0.5-5.9) | 2.7 (2.1-3.9) |
. | N, % . | |||||
---|---|---|---|---|---|---|
Line of therapy | First line | Second line | Third line | Fourth line | Fifth line | Sixth line |
Treated | 66 | 38∗ | 21† | 14‡ | 4 | 3 |
Achieved complete response | 35 (53%) | 18 (51%) | 7 (35%) | 2 (17%) | 2 (50%) | 2 (67%) |
Relapsed after complete response | 22/35 (63%) | 11/18 (61%) | 6/7 (86%) | 2/2 (100%) | 1/2 (50%) | 0/2 (0%) |
Time from previous line (IQR), mo | NR | 3.4 (2.7-7.6) | 3.1 (1.9,6.1) | 3.9 (2.3-6.6) | 1.4 (0.5-5.9) | 2.7 (2.1-3.9) |